Candriam Equities L Oncology Impact R/ LU1864482945 /
| NAV1/22/2025 | Chg.+0.5600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 152.0400GBP | +0.37% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | -5.91 | 1.22 | 1.97 | -2.19 | 6.24 | -1.60 | 6.65 | -1.78 | 1.67 | -3.00 | 1.57 | +0.35% |
| 2022 | -9.65 | -1.77 | 6.64 | -1.28 | -1.72 | 3.81 | 4.15 | 1.29 | -0.68 | 3.77 | 2.54 | -4.41 | +1.60% |
| 2023 | -0.20 | -2.27 | -0.74 | 1.14 | -1.18 | -2.45 | -0.32 | -0.52 | -1.64 | -5.82 | 4.68 | 4.98 | -4.69% |
| 2024 | 1.46 | 4.83 | 1.62 | -2.54 | 0.78 | 1.90 | 4.06 | 1.80 | -5.03 | -1.54 | -1.14 | -5.42 | - |
| 2025 | 4.12 | - | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.89% | 12.05% | 11.38% | 14.21% | -% |
| Sharpe ratio | 7.79 | -1.17 | 0.02 | 0.11 | - |
| Best month | +4.12% | +4.12% | +4.83% | +6.64% | - |
| Worst month | -5.42% | -5.42% | -5.42% | -9.65% | - |
| Maximum loss | -1.77% | -13.04% | -13.04% | -18.40% | - |
| Outperformance | - | - | - | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,233.5400 | +0.12% | +4.74% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,388.6799 | +0.25% | +5.13% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,150.4700 | +3.05% | +13.42% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,495.7000 | -0.20% | +3.74% | |
| Candriam Equities L Oncology Imp... | paying dividend | 18,769.0000 | -3.56% | -3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,937.8101 | -2.03% | -3.89% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,777.5100 | +3.37% | +19.10% | |
| Candriam Equities L Oncology Imp... | reinvestment | 189.3800 | -2.95% | -6.57% | |
| Candriam Equities L Oncology Imp... | reinvestment | 236.1700 | +3.29% | +9.46% | |
| Candriam Equities L Oncology Imp... | paying dividend | 217.9400 | -1.12% | +0.86% | |
| Candriam Equities L Oncology Imp... | paying dividend | 177.4800 | -0.29% | +3.44% | |
| Candriam Equities L Oncology Imp... | reinvestment | 152.0400 | +2.95% | +13.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 251.6700 | +4.17% | +12.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 188.4100 | -3.33% | -7.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 266.1300 | -0.29% | +3.43% | |
| Candriam Equities L Oncology Imp... | reinvestment | 177.9800 | -2.06% | -4.10% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,677.2000 | -0.20% | +3.74% | |
| Candriam Equities L Oncology Imp... | reinvestment | 151.4200 | -0.74% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 253.2100 | -1.12% | +0.86% |
Performance
| YTD | +4.12% | ||
|---|---|---|---|
| 6 Months | -5.96% | ||
| 1 Year | +2.95% | ||
| 3 Years | +13.04% | ||
| 5 Years | - | ||
| Since start | +1.36% | ||
| Year | |||
| 2023 | -4.69% | ||
| 2022 | +1.60% | ||
| 2021 | +0.35% | ||